"It will take the company about 3 months to get the drug launched. So, the drug should be available in the United States by April, assuming that the drug is approved. At the present, there is no reason to suspect that it will not be approved but one never knows and Acorda is being appropriately cautious."
News 
Market Data 
Discover 
